Artificial intelligence and global health (WP1626)

Podcast

We discuss the potential of AI to deliver improved health outcomes for individuals in low resource settings through the use of simple applications that build on existing health care approaches. The discussion also focused on ethical implications of using AI for global health, the likelihood of it exacerbating existing inequalities, and issues relating to trust, […]

Ebola – lessons learned from the last outbreak (WP1496)

Podcast

We discuss if the outbreak taught us anything, what we learnt about military involvement, if anyone considered if the outbreak was intentional and if so, was the response different. Contributors: Akin Abayomi, Head of Department, Division of Haematology, Stellenbosch University Gary Kobinger, Director, Infectious Disease Research Center; Professor, Department of Immunology Microbiology, Faculty of Medicine

AMR (antimicrobial resistance) (WP1477)

Podcast

We talk about which diseases are prone to reoccurrence, how resistance arises, what the pressure points on AMR are in Africa and how you tackle the self-medication of medicine. Contributors: Emmanuel Makasa, Counsellor, Health, Permanent Mission of the Republic of Zambia to the United Nations Office and Other International Organisations, Geneva Marc Mendelson, Professor of […]

The science of genomics (WP1463)

Podcast

We discuss what genomics is, why doctors are interested in it and what personalised medicine is. Contributors: Fahd Al-Mulla, Professor of Molecular Pathology, Faculty of Medicine, Kuwait University; Director, Genatak, The Center of Genomic Medicine, Kuwait City Soo Teo, Chief Executive Officer; Head of Breast Cancer Research Programme, Cancer Research Malaysia

How Ebola was destroyed (WP1447)

Podcast

We talk about the role of community health workers, how an agency who isn’t local deals with the outbreak and what organisations learn from a situation such as this. Contributors: Foday Sawi Lahai, Deputy Minister of Health and Sanitation, Ministry of Health and Sanitation, Freetown, Sierra Leone Katie Taylor, Deputy Assistant Administrator, Bureau for Global […]

Eliminating malaria with determination, not just hope (WP1390)

Podcast

We talk about working with cross border collaboration and ask how you get leaders from different countries to come up with a collective policy. Contributors: Nafsiah Mboi, Envoy, Asia Pacific Leaders Malaria Alliance (APLMA), Jakarta Richard Kamwi, Elimination 8 Ambassador; Former Minister of Health and Social Affairs, Windhoek, Namibia Other podcast in the series Malaria […]

Malaria – the 70 year story (WP1390)

Podcast

To celebrate our forthcoming 70th anniversary in 2016, we will be publishing a range of dialogues. In this first podcast, we discuss the 70 year success story of malaria and talk about what has changed over the years. Contributor: Richard Feachem, Director, Global Health Group, UCSF Global Health Sciences, University of California, San Francisco, United […]

Ebola – the next steps (WP1409)

Podcast

We talk about health systems in West Africa after Ebola and ask how affected countries can rebuild their health services, through domestic investment in healthcare, training health workers, using IT effectively and increasing regional collaboration. Contributors: Pape Gaye, President and Chief Executive Officer, IntraHealth International, Chapel Hill Perry Nelson, Director, Management Information Systems, National Health […]

The rise of antimicrobial resistance (WP1399)

Podcast

We discuss the threat that AMR poses and what is being done about it, how the international community comes together and what the practical challenges are for implementation. We ask what will happen after the global action plan in May. Contributors: Keiji Fukuda, Assistant Director General, Health Security, World Health Organisation, Geneva Abdul Ghafur, Consultant […]

Counterfeit and falsified medicines (WP1185)

Podcast

In 2008 in Ghana, 35% of anti-malarias were found to be substandard or counterfeit. To address this, companies that have produced fake products are being named and shamed. Through collaborative work, in 2011, this figure had reduced to below 5%. But this is just the start of what needs to be done. Contributor is: Stephen […]